Clinical Trial Update: A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status [Phase 3]

View source ↗

Summary

Phase III trial investigating anus-preservation in low rectal adenocarcinoma based on MMR/MSI status involving toripalimab and radiation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• Toripalimab (Toripalimab)
• radiation

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Toripalimab, Radiation | Phase 3 | Status: UNKNOWN